載入...
Functional characterization of the selective pan-allele anti-SIRPα antibody ADU-1805 that blocks the SIRPα–CD47 innate immune checkpoint
BACKGROUND: Accumulating preclinical data indicate that targeting the SIRPα/CD47 axis alone or in combination with existing targeted therapies or immune checkpoint inhibitors enhances tumor rejection. Although several CD47-targeting agents are currently in phase I clinical trials and demonstrate act...
Na minha lista:
發表在: | J Immunother Cancer |
---|---|
Main Authors: | , , , , , , , , , , , , , , , |
格式: | Artigo |
語言: | Inglês |
出版: |
BioMed Central
2019
|
主題: | |
在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6894304/ https://ncbi.nlm.nih.gov/pubmed/31801627 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40425-019-0772-0 |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|